A Randomized, Open-label, Phase 2b Study to Compare the Efficacy of DSP107 in Combination with Atezolizumab Versus Fruquintinib in Patients with Advanced Microsatellite Stable Colorectal Cancer
Clinical Trial Grant
Awarded By
Kahr Bio Australia Pty Ltd
Start Date
March 24, 2026
End Date
March 26, 2031
Awarded By
Kahr Bio Australia Pty Ltd
Start Date
March 24, 2026
End Date
March 26, 2031